Ascendis Pharma A/S Overview
Ascendis Pharma A/S Target Price
Analysts' 12-month price predictions for ASND.
Share Price
$151.25
Average Target Price
$180.00
19% upside
19% upside1 analysts in the last 4 months
High: $180 | Low: $180
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-02-18 | Morgan Stanley | $180 | 19% upside |  |
| 2024-09-23 | Bank of America SecuritiesTazeen Ahmad | $191 | 26.3% upside | |
| 2024-09-17 | Evercore ISIGavin Clark-Gartner | $205 | 35.5% upside | |
| 2024-09-17 | OppenheimerLeland Gershell | $190 | 25.6% upside | |
| 2024-09-17 | CitigroupDavid Lebowitz | $207 | 36.9% upside | |
| 2024-09-17 | Wells FargoDerek Archila | $289 | 91.1% upside | |
| 2024-09-16 | Bank of America SecuritiesTazeen Ahmad | $175 | 15.7% upside | |
| 2024-09-16 | Goldman SachsPaul Choi | $200 | 32.2% upside | |
| 2024-09-13 | CitigroupDavid Lebowitz | $178 | 17.7% upside | |
| 2024-09-05 | OppenheimerLeland Gershell | $180 | 19% upside | |
| 2024-08-13 | JefferiesKelly Shi | $196 | 29.6% upside | |
| 2024-05-30 | Stifel NicolausAlex Thompson | $200 | 32.2% upside | |
| 2024-05-15 | Morgan StanleyVikram Purohit | $140 |  7.4% downside | |
| 2024-03-14 | Evercore ISIJosh Schimmer | $191 | 26.3% upside | |
| 2023-01-03 | Wells Fargo | $177 | 17% upside | |
| 2022-11-15 | Morgan Stanley | $148 | 2.1% downside | |
| 2022-11-14 | Leerink Partners | $148 | 2.1% downside | |
| 2022-11-14 | Wedbush | $164 | 8.4% upside | |
| 2022-03-20 | Bank of America SecuritiesTazeen Ahmad | $161 | 6.4% upside | |
| 2022-02-28 | CitigroupDavid Lebovitz | $187 | 23.6% upside | |
| 2022-01-06 | Cowen & Co.Yaron Werber | $136 | 10.1% downside | |
| 2021-07-07 | Canaccord GenuityMichelle Gilson | $196 | 29.6% upside | |
| 2021-06-14 | Cantor FitzgeraldAlethia Young | $201 | 32.9% upside | |